Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1/2 1

Status

Withdrawn 1Terminated 1Completed 1

Sponsor Class

OTHER 3

Study Type

Observational 6Interventional 3

Sponsor

Cancer Type

Endocrine 1

Conditions

Breast Neoplasms 10184Neoplasms 7810Carcinoma, Non-Small-Cell Lung 5760Prostatic Neoplasms 5024Colorectal Neoplasms 4606Lung Neoplasms 3725Leukemia, Myeloid, Acute 3102Neoplasm Metastasis 3083Multiple Myeloma 3082Pancreatic Neoplasms 2845Melanoma 2653Ovarian Neoplasms 2573Lymphoma 2571Carcinoma, Hepatocellular 2480Stomach Neoplasms 2330Recurrence 2230Head and Neck Neoplasms 2103Precursor Cell Lymphoblastic Leukemia-Lymphoma 2086Lymphoma, Non-Hodgkin 2058Leukemia 2013Brain Neoplasms 1905Glioblastoma 1797Colonic Neoplasms 1791Leukemia, Lymphocytic, Chronic, B-Cell 1771Rectal Neoplasms 1720Uterine Cervical Neoplasms 1693Squamous Cell Carcinoma of Head and Neck 1654Lymphoma, Follicular 1652Lymphoma, Large B-Cell, Diffuse 1597Carcinoma, Renal Cell 1577

Interventions

Probiotics 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Generalized Anxiety Disorder × Clear all
NCT03674138 2026-02-06

Pharmacogenomic-Guided Antidepressant Drug Prescribing in Cancer Patients

H. Lee Moffitt Cancer Center and Research Institute

Phase NA Completed
99 enrolled

Generalized Anxiety Disorder, Anxiety Disorders, Depression, Depressive Disorder, Major, Depressive Disorder, Neoplasms

NCT04784182 2023-08-24

ABBCS

Auburn University

Phase NA Terminated
3 enrolled 10 charts

Generalized Anxiety Disorder

NCT02072252 2017-08-17

TODAY!

Northwestern University

Phase 1/2 Withdrawn
Endocrine

Generalized Anxiety Disorder, Alzheimer Disease, Anxiety Disorders, Bisexuality, Depression, Homosexuality, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡